ALKERMES | GJELD



Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 366M 2024-12
Amgen USD 60.1B 299M 2024-12
Biogen USD 6.3B 1.9M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
J&J USD 36.63B 883M 2024-12
Malin Corporation EUR 0 100K 2024-06
Merck USD 37.11B 1.02B 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Otsuka Holdings JPY 189.38B 149.6B 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



ALKERMES GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.